{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:13:55Z","timestamp":1793920435086,"version":"4.8.0"},"posted":{"date-parts":[[2026,7,9]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":67,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CDC Foundation","award":["75D30122C15481"],"award-info":[{"award-number":["75D30122C15481"]}]},{"name":"National Institutes of Health SIG grant","award":["#S10 OD026929"],"award-info":[{"award-number":["#S10 OD026929"]}]},{"name":"Shared Instrumentation Grant (SIG) Program","award":["S10OD025052"],"award-info":[{"award-number":["S10OD025052"]}]},{"name":"European Commission, Innovative Medicines Initiative 2","award":["115910"],"award-info":[{"award-number":["115910"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Despite decades of widespread vaccination, whooping cough caused by\n                  <jats:italic>Bordetella pertussis<\/jats:italic>\n                  (Bp) continues to circulate globally. To define correlates of protection and mechanisms underlying symptom development, we characterized systemic and mucosal immune responses in a controlled human infection model of Bp (\n                  <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05136599\">NCT05136599<\/jats:ext-link>\n                  ). Healthy vaccinated adults were intranasally challenged with escalating Bp doses and classified as symptomatic, asymptomatic, or non-infected. Longitudinal sampling of blood and nasal mucosa allowed mapping of antibody titers, immune cell subset frequencies, cytokine concentrations, gene expression, and T cell activation and polarization.\n                <\/jats:p>\n                <jats:p>Non-infected participants exhibited significantly higher pre-challenge serum antigen-specific IgG titers. Post-challenge, only symptomatic participants developed robust antigen-specific IgG responses. Notably, infection-induced IgG responses displayed slower kinetics and a lower overall magnitude compared to the rapid day 7 peak observed following tetanus, diphtheria, and acellular pertussis (Tdap) booster vaccination. Furthermore, symptomatic infection was driven by pronounced nasal inflammation characterized by increased HLA-DRLJ myeloid cells and upregulated mucosal NF-\u03baB signaling on day 7. Systemic immune responses were comparatively modest post-challenge: plasma cytokine concentrations decreased independently of clinical outcome, peripheral blood mononuclear cell transcriptomes and antigen-specific T cell activation and polarization remained largely unchanged.<\/jats:p>\n                <jats:p>These findings identify pre-existing serum antibodies as potential correlates of protection from Bp infection and suggest that symptom development is associated with localized mucosal inflammation dominated by a myeloid cell response. The predominance of nasal over systemic immune activation highlights the importance of mucosal immunity in controlling Bp and provides critical insights to guide the design of next-generation vaccines aimed at preventing both disease and transmission.<\/jats:p>","DOI":"10.64898\/2026.06.26.26356067","type":"posted-content","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:00:15Z","timestamp":1783656015000},"source":"Crossref","is-referenced-by-count":1,"title":["Pre-existing antibodies predict protection while mucosal inflammation correlates with symptomatic\n                  <i>Bordetella pertussis<\/i>\n                  infection"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-9249","authenticated-orcid":false,"given":"Lisa","family":"Willemsen","sequence":"first","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Ren","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Shinde","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Thrupp","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyeun","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aanya","family":"Gupta","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Orfield","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Kojima","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Azhan","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Frazier","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hariri","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Halperin","sequence":"additional","affiliation":[{"name":"Canadian Center for Vaccinology, Dalhousie University and the IWK Health Centre and Nova Scotia Health Authority, Halifax, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"ElSherif","sequence":"additional","affiliation":[{"name":"Canadian Center for Vaccinology, Dalhousie University and the IWK Health Centre and Nova Scotia Health Authority, Halifax, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Peters","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA"},{"name":"Department of Medicine, University of California San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026071106250728000_2026.06.26.26356067v1.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q736"},{"key":"2026071106250728000_2026.06.26.26356067v1.2","unstructured":"(CDC) CfDCaP. Pertussis Surveillance and Trends 2025 [updated December 2, 2025. Available from: https:\/\/www.cdc.gov\/pertussis\/php\/surveillance\/index.html."},{"issue":"11","key":"2026071106250728000_2026.06.26.26356067v1.3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41579-024-01064-8","article-title":"Pertussis vaccines, epidemiology and evolution","volume":"22","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"2026071106250728000_2026.06.26.26356067v1.4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003264"},{"key":"2026071106250728000_2026.06.26.26356067v1.5","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.11.1843"},{"key":"2026071106250728000_2026.06.26.26356067v1.6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1314688110"},{"key":"2026071106250728000_2026.06.26.26356067v1.7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit046"},{"key":"2026071106250728000_2026.06.26.26356067v1.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3836"},{"key":"2026071106250728000_2026.06.26.26356067v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2012.54"},{"key":"2026071106250728000_2026.06.26.26356067v1.10","doi-asserted-by":"crossref","unstructured":"Valeri V , Sochon A , Cousu C , Chappert P , Lecoeuche D , Blanc P , et al. The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings. JCI Insight. 2022;7(21).","DOI":"10.1172\/jci.insight.157034"},{"key":"2026071106250728000_2026.06.26.26356067v1.11","doi-asserted-by":"publisher","DOI":"10.1086\/593682"},{"issue":"6","key":"2026071106250728000_2026.06.26.26356067v1.12","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1128\/iai.65.6.2168-2174.1997","article-title":"Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines","volume":"65","year":"1997","journal-title":"Infect Immun."},{"issue":"11","key":"2026071106250728000_2026.06.26.26356067v1.13","doi-asserted-by":"crossref","first-page":"e0286925","DOI":"10.1371\/journal.pone.0286925","article-title":"Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge","volume":"18","year":"2023","journal-title":"PLoS One"},{"key":"2026071106250728000_2026.06.26.26356067v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.01.013"},{"key":"2026071106250728000_2026.06.26.26356067v1.15","doi-asserted-by":"crossref","unstructured":"ElSherif MS , Redden KL , Langley JM , Ye L , Blanchard W , Smith B , et al. A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420. medRxiv. 2026(TBD).","DOI":"10.64898\/2026.06.09.26355227"},{"key":"2026071106250728000_2026.06.26.26356067v1.16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz840"},{"key":"2026071106250728000_2026.06.26.26356067v1.17","doi-asserted-by":"crossref","unstructured":"Diks AM , de Graaf H , Teodosio C , Groenland RJ , de Mooij B , Ibrahim M , et al. Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge. J Clin Invest. 2023;133(5).","DOI":"10.1172\/JCI163121"},{"issue":"1","key":"2026071106250728000_2026.06.26.26356067v1.18","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1038\/s41467-025-58460-8","article-title":"Th1 polarization in Bordetella pertussis vaccine responses is maintained through a positive feedback loop","volume":"16","year":"2025","journal-title":"Nat Commun"},{"key":"2026071106250728000_2026.06.26.26356067v1.19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600318"},{"key":"2026071106250728000_2026.06.26.26356067v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2023.06.015"},{"key":"2026071106250728000_2026.06.26.26356067v1.21","doi-asserted-by":"publisher","DOI":"10.1172\/jci121309"},{"key":"2026071106250728000_2026.06.26.26356067v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2016.05.002"},{"key":"2026071106250728000_2026.06.26.26356067v1.23","doi-asserted-by":"crossref","unstructured":"van der Lee S , Hendrikx LH , Sanders EAM , Berbers GAM , Buisman AM . Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles. Front Immunol. 2018;9:51.","DOI":"10.3389\/fimmu.2018.00051"},{"key":"2026071106250728000_2026.06.26.26356067v1.24","doi-asserted-by":"crossref","first-page":"8202067","DOI":"10.1155\/2020\/8202067","article-title":"Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy","volume":"2020","year":"2020","journal-title":"J Immunol Res"},{"key":"2026071106250728000_2026.06.26.26356067v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0114-2"},{"key":"2026071106250728000_2026.06.26.26356067v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07748-8"},{"key":"2026071106250728000_2026.06.26.26356067v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00220-6"},{"issue":"1","key":"2026071106250728000_2026.06.26.26356067v1.28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcmgh.2020.08.003","article-title":"TNFSF15 Promotes Antimicrobial Pathways in Human Macrophages and These Are Modulated by TNFSF15 Disease-Risk Variants","volume":"11","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"2026071106250728000_2026.06.26.26356067v1.29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41420-021-00410-6","article-title":"PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR\/Akt\/NF-kappaB\/IL8 pathway","volume":"7","year":"2021","journal-title":"Cell Death Discov"},{"key":"2026071106250728000_2026.06.26.26356067v1.30","doi-asserted-by":"publisher","DOI":"10.3390\/biom5031302"},{"key":"2026071106250728000_2026.06.26.26356067v1.31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2702"},{"key":"2026071106250728000_2026.06.26.26356067v1.32","doi-asserted-by":"publisher","DOI":"10.1007\/s003950050170"},{"key":"2026071106250728000_2026.06.26.26356067v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00227-8"},{"key":"2026071106250728000_2026.06.26.26356067v1.34","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.5.1211"},{"key":"2026071106250728000_2026.06.26.26356067v1.35","doi-asserted-by":"crossref","unstructured":"de Graaf H , Gbesemete DF , Hill AR , Froberg J , Ibrahim MM , Dale AP , et al. Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study. Lancet Microbe. 2026:101313.","DOI":"10.1016\/j.lanmic.2025.101313"},{"key":"2026071106250728000_2026.06.26.26356067v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00226-6"},{"key":"2026071106250728000_2026.06.26.26356067v1.37","doi-asserted-by":"crossref","unstructured":"Barkoff AM , Grondahl-Yli-Hannuksela K , He Q . Seroprevalence studies of pertussis: what have we learned from different immunized populations. Pathog Dis. 2015;73(7).","DOI":"10.1093\/femspd\/ftv050"},{"key":"2026071106250728000_2026.06.26.26356067v1.38","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.3.480"},{"key":"2026071106250728000_2026.06.26.26356067v1.39","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0382-8"},{"key":"2026071106250728000_2026.06.26.26356067v1.40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz531"},{"key":"2026071106250728000_2026.06.26.26356067v1.41","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-014-0663-4"},{"key":"2026071106250728000_2026.06.26.26356067v1.42","first-page":"115","article-title":"Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamics","volume":"122","year":"2011","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2026071106250728000_2026.06.26.26356067v1.43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1602051"},{"key":"2026071106250728000_2026.06.26.26356067v1.44","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae034"},{"key":"2026071106250728000_2026.06.26.26356067v1.45","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-013-0242-1"},{"issue":"6","key":"2026071106250728000_2026.06.26.26356067v1.46","doi-asserted-by":"crossref","first-page":"e0018925","DOI":"10.1128\/msphere.00189-25","article-title":"Highlights of the 14th International Bordetella Symposium","volume":"10","year":"2025","journal-title":"mSphere"},{"issue":"12","key":"2026071106250728000_2026.06.26.26356067v1.47","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1038\/s41564-025-02166-6","article-title":"Respiratory immunization using antibiotic-inactivated Bordetella pertussis confers T cell-mediated protection against nasal infection in mice","volume":"10","year":"2025","journal-title":"Nat Microbiol"},{"key":"2026071106250728000_2026.06.26.26356067v1.48","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.7.4217-4223.2001"},{"key":"2026071106250728000_2026.06.26.26356067v1.49","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.0.CO;2-#"},{"key":"2026071106250728000_2026.06.26.26356067v1.50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900169"},{"key":"2026071106250728000_2026.06.26.26356067v1.51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169086"},{"key":"2026071106250728000_2026.06.26.26356067v1.52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095192"},{"key":"2026071106250728000_2026.06.26.26356067v1.53","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2026071106250728000_2026.06.26.26356067v1.54","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr026"},{"key":"2026071106250728000_2026.06.26.26356067v1.55","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"2026071106250728000_2026.06.26.26356067v1.56","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt656"},{"key":"2026071106250728000_2026.06.26.26356067v1.57","doi-asserted-by":"crossref","unstructured":"Chen Y , Chen L , Lun ATL , Baldoni PL , Smyth GK . edgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets. Nucleic Acids Res. 2025;53(2).","DOI":"10.1093\/nar\/gkaf018"},{"key":"2026071106250728000_2026.06.26.26356067v1.58","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2026071106250728000_2026.06.26.26356067v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6"},{"key":"2026071106250728000_2026.06.26.26356067v1.60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2026071106250728000_2026.06.26.26356067v1.61","unstructured":"Gene Ontology C, Aleksander SA , Balhoff J , Carbon S , Cherry JM , Drabkin HJ , et al. The Gene Ontology knowledgebase in 2023. Genetics. 2023;224(1)."},{"key":"2026071106250728000_2026.06.26.26356067v1.62","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.07.023"},{"key":"2026071106250728000_2026.06.26.26356067v1.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.11.026"},{"key":"2026071106250728000_2026.06.26.26356067v1.64","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl5197"},{"issue":"4","key":"2026071106250728000_2026.06.26.26356067v1.65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s43018-022-00356-3","article-title":"Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology","volume":"3","year":"2022","journal-title":"Nat Cancer"},{"key":"2026071106250728000_2026.06.26.26356067v1.66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006976"},{"key":"2026071106250728000_2026.06.26.26356067v1.67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10802-z"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.26.26356067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:25:17Z","timestamp":1783776317000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.06.26.26356067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":67,"URL":"https:\/\/doi.org\/10.64898\/2026.06.26.26356067","relation":{},"subject":[],"published":{"date-parts":[[2026,7,9]]},"subtype":"preprint"}}